Literature DB >> 6121620

Gender differences in schizophrenia.

M V Seeman.   

Abstract

men with schizophrenia have an earlier age of onset, a somewhat inferior response to treatment and a generally poorer prognosis than women. These findings can perhaps be explained by the existence of two distinct forms of the illness, one with early onset, primarily affecting men, and one with later onset, primarily affecting women. There is not much evidence for this first view. Alternatively, non-specific cumulative stress factors may impinge selectively on the male, reaching the threshold of demonstrable illness at an earlier age. A third possibility is the existence of specific biological protective factors in the female, such as relatively bilateral representation of left hemisphere functions or relative dopaminergic inhibition by estrogens.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6121620     DOI: 10.1177/070674378202700204

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  26 in total

1.  The epidemiology of schizophrenia.

Authors:  M V Seeman
Journal:  Can Fam Physician       Date:  1984-02       Impact factor: 3.275

2.  The Sex Chromosome Hypothesis of Schizophrenia: Alive, Dead, or Forgotten? A Commentary and Review.

Authors:  William K Bache; Lynn E DeLisi
Journal:  Mol Neuropsychiatry       Date:  2018-08-20

3.  A genotype-phenotype research strategy for schizophrenia.

Authors:  W G Honer; A S Bassett; L Kopala; J L Kennedy
Journal:  Can J Psychiatry       Date:  1990-12       Impact factor: 4.356

4.  Striatal dopamine transporter availability with [123I]beta-CIT SPECT is unrelated to gender or menstrual cycle.

Authors:  Susan E Best; Philip M Sarrel; Robert T Malison; Marc Laruelle; Sami S Zoghbi; Ronald M Baldwin; John P Seibyl; Robert B Innis; Christopher H van Dyck
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

Review 5.  Schizophrenia: D4 receptor elevation. What does it mean?

Authors:  M V Seeman
Journal:  J Psychiatry Neurosci       Date:  1994-05       Impact factor: 6.186

6.  The modulation of brain dopamine and GABAA receptors by estradiol: a clue for CNS changes occurring at menopause.

Authors:  R Bossé; T DiPaolo
Journal:  Cell Mol Neurobiol       Date:  1996-04       Impact factor: 5.046

7.  Sex and diagnosis specific associations between DNA methylation of the oxytocin receptor gene with emotion processing and temporal-limbic and prefrontal brain volumes in psychotic disorders.

Authors:  Leah H Rubin; Jessica J Connelly; James L Reilly; C Sue Carter; Lauren L Drogos; Hossein Pournajafi-Nazarloo; Anthony C Ruocco; Sarah K Keedy; Ian Matthew; Neeraj Tandon; Godfrey D Pearlson; Brett A Clementz; Carol A Tamminga; Elliot S Gershon; Matcheri S Keshavan; Jeffrey R Bishop; John A Sweeney
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2015-11-09

8.  Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome.

Authors:  Deborah J Walder; Carrie W Holtzman; Jean Addington; Kristin Cadenhead; Ming Tsuang; Barbara Cornblatt; Tyrone D Cannon; Thomas H McGlashan; Scott W Woods; Diana O Perkins; Larry J Seidman; Robert Heinssen; Elaine F Walker
Journal:  Schizophr Res       Date:  2013-01-20       Impact factor: 4.939

9.  Dopamine and GABAA receptor imbalance after ovariectomy in rats: model of menopause.

Authors:  R Bossé; T Di Paolo
Journal:  J Psychiatry Neurosci       Date:  1995-11       Impact factor: 6.186

10.  Transnational stability of gender differences in schizophrenia? An analysis based on the WHO study on determinants of outcome of severe mental disorders.

Authors:  M Hambrecht; K Maurer; H Häfner; N Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.